Assyro AI

Orange Book product · Generic (ANDA)

ACETAMINOPHEN, ASPIRIN AND CAFFEINE

ACETAMINOPHEN; ASPIRIN; CAFFEINE

Generic (ANDA)ANDA 211695OTC AUROBINDO PHARMA LTD

At a glance

Feb 02, 2022

Approved

Generic (ANDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Feb 02, 2022

    4 yr 5 mo ago

  2. Today

Pharmaceutical detail

Active ingredient

ACETAMINOPHEN; ASPIRIN; CAFFEINE

Strength

250MG;250MG;65MG

Dosage form

TABLET

Route

ORAL

TE code

Not listed

Application

ANDA 211695

Product number

001

Marketing status

OTC

Reference listed drug (RLD)

No

Reference standard (RS)

No

Active-ingredient family

View full family

Generic (ANDA) of ACETAMINOPHEN; ASPIRIN; CAFFEINE

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.